In the search for ways to effectively combat age-related human disease, the enzyme sirtuin 6 (Sirt6) has recently become a focus of biochemical research. A targeted activation of Sirt6 could prevent or mitigate such diseases, for example some types of cancer. In a paper for the journal "Nat ... more
Prof. Dr. Paul Rösch
Universität Bayreuth, Forschungszentrum für Bio-Makromoleküle (FZ BIOmac)
studied physics at the universities of Karlsruhe and Heidelberg before receiving his doctorate at the Max Planck Institute for Medical Research in Heidelberg. This was followed by a post-doc at the University of Pennsylvania Medical School in the USA, and a post as research assistant at the Max Planck Institute for Medical Research in Heidelberg. In 1989, he completed his habilitation in biophysics at the University of Heidelberg. He has been head of the Department of Biopolymers since 1990 and Executive Director of the Research Centre for Bio-Macromolecules (RC BIOmac) at the University of Bayreuth since 2007. His key areas of research are NMR-based biomedical structural research, focusing in particular on the molecular basis of food allergies, and research into bacterial transcription as a target for new antibiotics.